Enzo Competitors
| ENZ Stock | USD 1.16 0.01 0.85% |
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Enzo Biochem competition on your existing holdings.
Enzo |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Enzo Biochem's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Enzo Biochem Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Enzo Biochem and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Enzo and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Enzo Biochem does not affect the price movement of the other competitor.
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Enzo Stock performing well and Enzo Biochem Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Enzo Biochem's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| FONR | 1.60 | (0.22) | 0.00 | (0.13) | 0.00 | 3.56 | 13.52 | |||
| BNR | 2.99 | (0.06) | 0.00 | 0.11 | 0.00 | 5.43 | 20.40 | |||
| SERA | 3.77 | 1.15 | 0.25 | 1.90 | 3.88 | 8.04 | 41.06 | |||
| OLK | 0.68 | (0.16) | 0.00 | (0.49) | 0.00 | 1.04 | 8.72 | |||
| LMDX | 9.51 | (1.38) | 0.00 | 0.42 | 0.00 | 21.78 | 77.78 | |||
| GTH | 0.43 | 0.12 | 0.13 | 1.25 | 0.04 | 1.33 | 3.89 | |||
| PMD | 1.67 | (0.49) | 0.00 | (0.71) | 0.00 | 3.04 | 10.49 | |||
| DRIO | 5.17 | (0.89) | 0.00 | (0.27) | 0.00 | 10.69 | 43.04 | |||
| CSTL | 3.18 | (0.18) | 0.00 | (0.02) | 0.00 | 5.87 | 39.62 | |||
| XGN | 3.52 | (0.40) | 0.00 | (0.78) | 0.00 | 9.26 | 32.68 |
Cross Equities Net Income Analysis
Compare Enzo Biochem and related stocks such as Fonar, Burning Rock BiotechLtd, and Sera Prognostics Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FONR | (7.5 M) | 5.8 M | 8.7 M | 10.4 M | 12.9 M | 15.7 M | 19.6 M | 21.2 M | 20.5 M | 11.7 M | 13.7 M | 17.2 M | 9.4 M | 10.8 M | 11.3 M |
| BNR | (131.3 M) | (131.3 M) | (131.3 M) | (131.3 M) | (131.3 M) | (131.3 M) | (131.3 M) | (131.3 M) | (177.5 M) | (168.3 M) | (373.7 M) | (796.7 M) | (971.2 M) | (707.7 M) | (743.1 M) |
| SERA | (20.4 M) | (20.4 M) | (20.4 M) | (20.4 M) | (20.4 M) | (20.4 M) | (20.4 M) | (20.4 M) | (20.4 M) | (20.4 M) | (21.6 M) | (36.2 M) | (44.2 M) | (36.2 M) | (38.1 M) |
| OLK | (17.9 M) | (17.9 M) | (17.9 M) | (17.9 M) | (17.9 M) | (17.9 M) | (17.9 M) | (17.9 M) | (17.9 M) | (17.9 M) | (6.8 M) | (38.3 M) | (12.9 M) | (31.7 M) | (33.2 M) |
| LMDX | (133.1 M) | (133.1 M) | (133.1 M) | (133.1 M) | (133.1 M) | (133.1 M) | (133.1 M) | (133.1 M) | (133.1 M) | (133.1 M) | (241 M) | (100.8 M) | (449.2 M) | (404.3 M) | (384.1 M) |
| PMD | (1.8 M) | 3.5 M | 3 M | 3.8 M | 3.2 M | 1.5 M | 6.7 M | 6.1 M | 4.6 M | 1.5 M | (3.9 M) | (665 K) | (1.1 M) | (4.2 M) | (3.9 M) |
| DRIO | (5.7 M) | (5.7 M) | (5.7 M) | (13.9 M) | (12.9 M) | (7.1 M) | (10.9 M) | (15.7 M) | (17.8 M) | (17.8 M) | (29 M) | (76.8 M) | (62.2 M) | (54.9 M) | (52.1 M) |
| CSTL | (12.4 M) | (12.4 M) | (12.4 M) | (12.4 M) | (12.4 M) | (12.4 M) | (12.4 M) | (12.4 M) | (6.4 M) | 5.3 M | (10.3 M) | (31.3 M) | (67.1 M) | (57.5 M) | (54.6 M) |
| XGN | (7.3 M) | (7.3 M) | (7.3 M) | (13.5 M) | (15 M) | (19.2 M) | (25.6 M) | (25.6 M) | (8 M) | (12 M) | (16.7 M) | (26.9 M) | (47.4 M) | (23.7 M) | (24.9 M) |
| BDSX | (26.2 M) | (26.2 M) | (26.2 M) | (26.2 M) | (26.2 M) | (26.2 M) | (26.2 M) | (26.2 M) | (26.2 M) | (31.4 M) | (36.5 M) | (44.5 M) | (80.4 M) | (52.1 M) | (54.8 M) |
| STIM | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | (16.1 M) | (24.1 M) | (34.3 M) | (32.3 M) | (35.6 M) | (39.2 M) | (30.2 M) | (31.7 M) |
| SHC | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (20.4 M) | (37.5 M) | 116.9 M | (233.6 M) | 51.4 M | 53.9 M |
Enzo Biochem and related stocks such as Fonar, Burning Rock BiotechLtd, and Sera Prognostics Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Enzo Biochem financial statement analysis. It represents the amount of money remaining after all of Enzo Biochem operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Enzo Biochem Competitive Analysis
The better you understand Enzo Biochem competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Enzo Biochem's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Enzo Biochem's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Enzo Biochem Competition Performance Charts
Five steps to successful analysis of Enzo Biochem Competition
Enzo Biochem's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Enzo Biochem in relation to its competition. Enzo Biochem's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Enzo Biochem in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Enzo Biochem's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Enzo Biochem, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Enzo Biochem position
In addition to having Enzo Biochem in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cryptocurrency ETFs Thematic Idea Now
Cryptocurrency ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Cryptocurrency ETFs theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cryptocurrency ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Enzo Biochem Correlation with its peers. For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Enzo Stock analysis
When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is Enzo Biochem's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enzo Biochem. If investors know Enzo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enzo Biochem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share 0.657 | Quarterly Revenue Growth 0.138 | Return On Assets (0.17) | Return On Equity (0.45) |
The market value of Enzo Biochem is measured differently than its book value, which is the value of Enzo that is recorded on the company's balance sheet. Investors also form their own opinion of Enzo Biochem's value that differs from its market value or its book value, called intrinsic value, which is Enzo Biochem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enzo Biochem's market value can be influenced by many factors that don't directly affect Enzo Biochem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enzo Biochem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enzo Biochem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enzo Biochem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.